title: Digging for data on harms in duloxetine trials.
authors.affiliation: Center for Drug Safety, Department of Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, MD, USA The BMJ, BMA House, London, UK.
authors.forename: Peter
authors.initials: P
authors.lastname: Doshi
authors.affiliation: Center for Drug Safety, Department of Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, MD, USA.
authors.forename: Julie
authors.initials: J
authors.lastname: Zito
authors.affiliation: Center for Drug Safety, Department of Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, MD, USA.
authors.forename: Susan
authors.initials: S
authors.lastname: dosReis
mesh_terms: D018759:Adrenergic Uptake Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use*; D016907:Adverse Drug Reaction Reporting Systems / Q000592:standards*; D000928:Antidepressive Agents / Q000009:adverse effects* / Q000627:therapeutic use*; D059019:Clinical Coding; D002986:Clinical Trials as Topic / Q000592:standards*; D003865:Major Depressive Disorder / Q000188:drug therapy*; D000068736:Duloxetine Hydrochloride; D006801:Humans; D016032:Randomized Controlled Trials as Topic / Q000592:standards*; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use*; D013405:Suicide; D013876:Thiophenes / Q000009:adverse effects* / Q000627:therapeutic use*
chemical_list: D018759:Adrenergic Uptake Inhibitors; D000928:Antidepressive Agents; D000068736:Duloxetine Hydrochloride; D017367:Selective Serotonin Reuptake Inhibitors; D013876:Thiophenes